Overview
Obligated since award on contracts active FY2021–FY2026
Click a company to open its profile.
Insight FDA OFFICE OF ACQ GRANT SVCS (75F401) is its largest buyer. See more on the Buyers tab
Agencies report with a delay; the latest year will rise
Hover over a year to see its value.
Insight Largest year: $620K in FY2001; since FY2021, $88.3K in FY2021. See more on the Contracts tab
$1.26M since award = $1.05M in FY2021–FY2026 + $216K before FY2021
Click a state to open its page.
- Maryland$933K · 74%
- Massachusetts$239K · 19%
- California$89.4K · 7.1%
Insight 74% was performed in Maryland. See more on the Contracts tab
Contracts
8 contracts with an action since FY2021
Click a tile to open its contract.
Insight Stand-alone contracts hold 100% of these contracts' obligations.
Click a bar to open its industry page.
Insight 100% under NAICS 622310.
Current end date of each prime contract with an action since FY2021
Hover over a month to see its value.
Dana-farber Cancer Institute, Inc. prime contracts with an action in FY2021–FY2026
Find a contract by vehicle, office or end date; sort by money to see the largest.
1 end within 12 months.
Showing 1–8 of 8 contracts
| Since award, US$ | |||||
|---|---|---|---|---|---|
| Parent contract (IDVIDV: the record type for any contract that exists to take orders: IDIQs, GWACs, GSA Schedules, BPAs and basic ordering agreements. Glossary) | ObligatedObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary | ||||
| 75F40126C00068 | Stand-alone | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $933,028 | Sep 29, 2027 | Ends within 12 months |
| 36C26121P0710 | Stand-alone | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $167,822 | Mar 30, 2023 | Ended |
| 36C26120P1370 | Stand-alone | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $70,744 | Feb 13, 2021 | Ended |
| 36C26121P1414 | Stand-alone | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $45,071 | Sep 30, 2021 | Ended |
| 36C26119P1448 | Stand-alone | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $44,292 | Sep 30, 2019 | Ended |
| 75N98F20P00013 | Stand-alone | NATIONAL INSTITUTES OF HEALTH NINR (75N98F) | $0 | Aug 31, 2021 | Ended |
| 75N91022P00185 | Stand-alone | NIH NCI (75N910) | $0 | Jan 31, 2022 | Ended |
| 36C24120P1142 | Stand-alone | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $0 | Sep 17, 2021 | Ended |
Buyers
Click a bar to open its office page.
3 more rows with $0 or less, not drawn.
Insight Food and Drug Administration placed 74%.
Contracting offices that awarded its prime contracts, FY2021–FY2026
See which offices award its contracts.
4 offices awarded only one contract.
Showing 1–5 of 5 offices
| Contracts active FY2021–FY2026; obligated since award, US$ | |||||
|---|---|---|---|---|---|
| FDA OFFICE OF ACQ GRANT SVCS (75F401) | Food and Drug Administration | 1 | $933,028 | Sep 25, 2026 | Sep 25, 2026 |
| 261-NETWORK CONTRACT OFFICE 21 (36C261) | Department of Veterans Affairs | 4 | $327,929 | Aug 8, 2019 | Mar 28, 2022 |
| NATIONAL INSTITUTES OF HEALTH NINR (75N98F) | National Institutes of Health | 1 | $0 | May 14, 2020 | Jan 24, 2025 |
| NIH NCI (75N910) | National Institutes of Health | 1 | $0 | Jan 18, 2022 | Jan 31, 2022 |
| 241-NETWORK CONTRACT OFFICE 01 (36C241) | Department of Veterans Affairs | 1 | $0 | Sep 18, 2020 | May 28, 2021 |
Teaming
Subcontracts Dana-farber Cancer Institute, Inc. received, by prime order
Whom it works under and on what.
8 subcontracts from 7 primes.
Showing 1–8 of 8 subcontracts
| The Univeristy Of Texas M.d. Anderson Cancer Center | HHSN26100010under HHSN261201200034I | NIH NCI (75N910) | $333,325 | Nov 22, 2019 |
| The Wistar Institute Of Anatomy And Biology | HHSN272201100018C | NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | $328,554 | Jul 27, 2015 |
| University Of Massachusetts Medical School | HR001111C0095 | DEF ADVANCED RESEARCH PROJECTS AGCY (HR0011) | $219,995 | Oct 8, 2014 |
| Trustees Of Dartmouth College | HHSO100201100024C | Office 00100 | $169,794 | Sep 23, 2013 |
| Brigham & Womens Hospital Inc. | 75F40122C00181 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $134,159 | Apr 27, 2023 |
| Cincinnati Univ Of | 75A50123C00052 | BARDA - ASPR / DAAPPO / BARDA DCMA (75A501) | $81,504 | Jun 18, 2025 |
| The Univeristy Of Texas M.d. Anderson Cancer Center | HHSN26100002under HHSN261201200034I | NIH NCI (75N910) | $54,576 | Jan 7, 2015 |
| Icf Macro Inc. | HHSN26100008under HHSN261201200010I | NIH NCI (75N910) | $35,639 | Mar 18, 2014 |
Opportunities
Open opportunities matching Dana-farber Cancer Institute, Inc.'s registered industries
Notices in its 1 industry (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary): 622310
No open notice matches these industries today. New notices arrive every day.
Registration and contacts
Registration
- UEI
- DPMGH9MG1X67
- CAGE code
- 5E915
- Registration
- Active, expires Mar 9, 2027
- Entity type
- Corporate Entity (Tax Exempt)
- Location
- Boston, MA, 02215
- Congressional district
- MA-07
Registered industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary)
Registered in 1 industry; primary 622310
- 622310 Specialty (except Psychiatric and Substance Abuse) HospitalsPrimary
Contacts at Dana-farber Cancer Institute, Inc.
| Contact | Role | As of |
|---|---|---|
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Government business POC · Electronic business POCSAM.gov registrationAs of Mar 11, 2026 | Mar 11, 2026 |
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Alternate government business POC · Alternate electronic business POCSAM.gov registrationAs of Mar 11, 2026 | Mar 11, 2026 |
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Past performance POCSAM.gov registrationAs of Mar 11, 2026 | Mar 11, 2026 |
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Alternate past performance POCSAM.gov registrationAs of Mar 11, 2026 | Mar 11, 2026 |
Correct this listing
Tell us what to correct or add on the Dana-farber Cancer Institute, Inc. page. We check every request before we change a profile.